West Palm Beach, FL (PRWEB) June 12, 2014
On May 13, Health Canada issued an alert to all hospital and medical staff to inform them they are continuing to receive reports of complications including serious, life-altering ones associated with the use of the transvaginal mesh devices for the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The update also includes recommendations for surgical mesh for SUI and POP procedures and for patient management. (MDL-2187)
As a member of the Plaintiff’s Steering Committee for the multi-district litigation case against transvaginal mesh device manufacturers, Joseph A. Osborne of Babbitt Johnson Osborne & Le Clainche believes that the Health Canada alert goes beyond helping medical staff better understand transvaginal mesh injuries. “Through this alert, the Canadian government has obligated the medical community to be better at diagnosing and treating those suffering complications from transvaginal mesh injuries,” stated Osborne. “It also places more responsibility on the medical community to better diagnose and treat those suffering transvaginal mesh complications.”
The Health Canada alert sent to all hospitals focused on the following:
Mr. Osborne encourages people injured as a result of transvaginal mesh injuries, to speak to a transvaginal mesh attorney to determine if they be compensated for their injuries.
About Babbitt, Johnson, Osborne and Le Clainche
Since 1965, the law firm of Babbitt, Johnson, Osborne and Le Clainche, in West Palm Beach, Florida has been seeking justice for its clients against people and businesses whose negligent behavior has caused serious injury. To find out more about how Babbitt, Johnson, Osborne and Le Clainche can help, visit Babbitt-Johnson.com or call (888) 666-0523.